Owen A. Ross

43.8k total citations · 5 hit papers
324 papers, 16.6k citations indexed

About

Owen A. Ross is a scholar working on Neurology, Physiology and Neurology. According to data from OpenAlex, Owen A. Ross has authored 324 papers receiving a total of 16.6k indexed citations (citations by other indexed papers that have themselves been cited), including 215 papers in Neurology, 91 papers in Physiology and 87 papers in Neurology. Recurrent topics in Owen A. Ross's work include Parkinson's Disease Mechanisms and Treatments (191 papers), Neurological diseases and metabolism (79 papers) and Alzheimer's disease research and treatments (53 papers). Owen A. Ross is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (191 papers), Neurological diseases and metabolism (79 papers) and Alzheimer's disease research and treatments (53 papers). Owen A. Ross collaborates with scholars based in United States, Poland and United Kingdom. Owen A. Ross's co-authors include Dennis W. Dickson, Matthew J. Farrer, Zbigniew K. Wszołek, Neill R. Graff‐Radford, Bradley F. Boeve, David S. Knopman, Melissa E. Murray, Katya Rascovsky, Irene Maeve Rea and Bruce L. Miller and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Owen A. Ross

320 papers receiving 16.3k citations

Hit Papers

Classification of primary progressive aphasia and its var... 2011 2026 2016 2021 2011 2018 2011 2021 2025 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Classification of primary progressive aphasia and its variants
    2011 3.4k citations Maria‐Luisa Gorno‐Tempini, Argye E. Hillis et al. Neurology profile →
  2. Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
    2018 893 citations Owen A. Ross et al. profile →
  3. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study
    2011 677 citations Melissa E. Murray, Neill R. Graff‐Radford et al. profile →
  4. Neuropathology and molecular diagnosis of Synucleinopathies
    2021 198 citations Shunsuke Koga, Hiroaki Sekiya et al. profile →
  5. Widespread distribution of α-synuclein oligomers in LRRK2-related Parkinson’s disease
    2025 14 citations Hiroaki Sekiya, Owen A. Ross et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Owen A. Ross United States 59 8.1k 5.5k 3.6k 3.4k 3.3k 324 16.6k
Neill R. Graff‐Radford United States 70 6.3k 0.8× 7.2k 1.3× 2.7k 0.8× 2.9k 0.9× 2.8k 0.8× 275 17.2k
Karen Marder United States 85 12.1k 1.5× 6.1k 1.1× 3.1k 0.9× 3.3k 1.0× 2.9k 0.9× 341 24.8k
Eduardo E. Benarroch United States 73 6.7k 0.8× 2.9k 0.5× 2.5k 0.7× 3.2k 0.9× 2.1k 0.6× 351 17.4k
James B. Leverenz United States 69 6.1k 0.8× 6.2k 1.1× 3.3k 0.9× 1.2k 0.4× 3.0k 0.9× 253 14.7k
Zbigniew K. Wszołek United States 73 12.5k 1.5× 5.6k 1.0× 4.6k 1.3× 1.6k 0.5× 5.0k 1.5× 461 18.9k
Pietro Cortelli Italy 65 5.2k 0.6× 3.2k 0.6× 4.8k 1.3× 2.7k 0.8× 2.8k 0.8× 539 17.2k
Barbara Borroni Italy 60 4.8k 0.6× 5.0k 0.9× 2.2k 0.6× 2.8k 0.8× 3.3k 1.0× 361 13.1k
Paul G. Ince United Kingdom 80 9.2k 1.1× 6.3k 1.1× 5.5k 1.5× 1.2k 0.3× 5.1k 1.5× 295 21.7k
John C. van Swieten Netherlands 64 10.0k 1.2× 7.1k 1.3× 4.4k 1.2× 2.4k 0.7× 4.2k 1.3× 268 23.7k
Udo Rüb Germany 52 12.6k 1.6× 6.1k 1.1× 4.9k 1.4× 2.7k 0.8× 3.6k 1.1× 103 20.9k

Countries citing papers authored by Owen A. Ross

Since Specialization
Citations

This map shows the geographic impact of Owen A. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Owen A. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Owen A. Ross more than expected).

Fields of papers citing papers by Owen A. Ross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Owen A. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Owen A. Ross. The network helps show where Owen A. Ross may publish in the future.

Co-authorship network of co-authors of Owen A. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Owen A. Ross. A scholar is included among the top collaborators of Owen A. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Owen A. Ross. Owen A. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soto‐Beasley, Alexandra I., Michael G. Heckman, Yingxue Ren, et al.. (2025). Characterizing the expression profile of 3R tau pathology in Pick’s disease. Science Advances. 11(18). eadt6105–eadt6105. 1 indexed citations
2.
Turnbull, Marion T., Elizabeth R. Lesser, Rickey E. Carter, et al.. (2024). Nimodipine-associated standard dose reductions and neurologic outcomes after aneurysmal subarachnoid hemorrhage: the era of pharmacogenomics. The Pharmacogenomics Journal. 24(4). 19–19. 1 indexed citations
3.
Siuda, Joanna, Jarosław Sławek, Andreas Puschmann, et al.. (2024). Structural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275W. Cells. 13(18). 1540–1540. 2 indexed citations
4.
Heckman, Michael G., Patrick W. Johnson, Alexandra I. Soto‐Beasley, et al.. (2024). Associations of mitochondrial genomic variation with successful neurological aging. Mitochondrion. 78. 101948–101948.
5.
Olney, Kimberly C., Aleksandra Wojtas, Michael DeTure, et al.. (2024). Distinct transcriptional alterations distinguish Lewy body disease from Alzheimer’s disease. Brain. 148(1). 69–88. 3 indexed citations
6.
Tipton, Philip W., Alexandra I. Soto‐Beasley, Gregory S. Day, et al.. (2023). CWH43 Variants Are Associated With Disease Risk and Clinical Phenotypic Measures in Patients With Normal Pressure Hydrocephalus. Neurology Genetics. 9(5). e200086–e200086. 7 indexed citations
7.
Koga, Shunsuke, Michael A. Metrick, Lawrence I. Golbe, et al.. (2023). Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathologica Communications. 11(1). 88–88. 7 indexed citations
8.
Tunold, Jon‐Anders, Manuela Tan, Mathias Toft, et al.. (2023). Lysosomal Polygenic Burden Drives Cognitive Decline in Parkinson's Disease with Low Alzheimer Risk. Movement Disorders. 39(3). 596–601. 8 indexed citations
9.
Sekiya, Hiroaki, Shunsuke Koga, Michael DeTure, et al.. (2023). Frequency of Comorbid Pathologies and Their Clinical Impact in Multiple System Atrophy. Movement Disorders. 39(2). 380–390. 12 indexed citations
10.
Holla, Vikram V., Ravi Yadav, Nitish Kamble, et al.. (2022). PLA2G6-associated neurodegeneration in four different populations-case series and literature review. Parkinsonism & Related Disorders. 101. 66–74. 4 indexed citations
11.
Heckman, Michael G., Catherine Labbé, Ana Kolicheski, et al.. (2021). Fine-mapping of the non-coding variation driving the Caucasian LRRK2 GWAS signal in Parkinson's disease. Parkinsonism & Related Disorders. 83. 22–30. 5 indexed citations
12.
Heckman, Michael G., Patrick W. Johnson, Matthew Baker, et al.. (2021). Association of Mitochondrial DNA Genomic Variation With Risk of Pick Disease. Neurology. 96(13). e1755–e1760.
13.
Wernick, Anna I., Ronald L. Walton, Alexandra I. Soto‐Beasley, et al.. (2021). Frequency of spinocerebellar ataxia mutations in patients with multiple system atrophy. Clinical Autonomic Research. 31(1). 117–125. 13 indexed citations
14.
Wernick, Anna I., Ronald L. Walton, Alexandra I. Soto‐Beasley, et al.. (2021). Investigating ELOVL7 coding variants in multiple system atrophy. Neuroscience Letters. 749. 135723–135723. 2 indexed citations
15.
Heckman, Michael G., Patrick W. Johnson, Alexandra I. Soto‐Beasley, et al.. (2020). Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures. Acta Neuropathologica Communications. 8(1). 162–162. 9 indexed citations
16.
Koga, Shunsuke, Michael G. Heckman, Danielle Brushaber, et al.. (2020). Association of Tripartite Motif Containing 11 rs564309 With Tau Pathology in Progressive Supranuclear Palsy. Movement Disorders. 35(5). 890–894. 9 indexed citations
17.
Watzlawik, Jens O., Xu Hou, Dominika Fričová, et al.. (2020). Sensitive ELISA-based detection method for the mitophagy marker p-S65-Ub in human cells, autopsy brain, and blood samples. Autophagy. 17(9). 2613–2628. 35 indexed citations
18.
Deutschländer, Angela, Takuya Konno, Alexandra I. Soto‐Beasley, et al.. (2020). Association of MAPT subhaplotypes with clinical and demographic features in Parkinson’s disease. Annals of Clinical and Translational Neurology. 7(9). 1557–1563. 6 indexed citations
19.
Gorno‐Tempini, Maria‐Luisa, Argye E. Hillis, Sandra Weıntraub, et al.. (2011). Classification of primary progressive aphasia and its variants. Neurology. 76(11). 1006–1014. 3351 indexed citations breakdown →
20.
Hu, William T., Alice Chen‐Plotkin, Owen A. Ross, et al.. (2010). Novel CSF biomarkers for frontotemporal lobar degenerations. Neurology. 75(23). 2079–2086. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neill R. Graff‐Radford Breakdown of academic impact, for papers by Karen Marder Breakdown of academic impact, for papers by Eduardo E. Benarroch Breakdown of academic impact, for papers by James B. Leverenz Breakdown of academic impact, for papers by Zbigniew K. Wszołek Breakdown of academic impact, for papers by Pietro Cortelli Breakdown of academic impact, for papers by Barbara Borroni Breakdown of academic impact, for papers by Paul G. Ince Breakdown of academic impact, for papers by John C. van Swieten Breakdown of academic impact, for papers by Udo Rüb
Rankless by CCL
2026